Fulgent Agrees to Buy Texas Testing Firm Inform Diagnostics

Learn more about Fulgent Genetics’ agreement to buy Texas testing firm Inform Diagnostics for $170 million, boosting its non-Covid testing business.

Related Keywords

New York , United States , Boston , Massachusetts , Phoenix , Arizona , Houston , Texas , Kevin Degeeter , Ming Hsieh , Temple Fulgent Genetics Inc , Diagnostics Inc , Oppenheimer Co , Temple City Based Fulgent Genetics , Texas Based Inform Diagnostics , Avista Capital Partners , New York City , New York Based Oppenheimer , Los Angeles County , Inform Diagnostics , Inform Diagnostic , Inform Diagnostic Covid , Covid Omicron ,